1. Stocks
    2. /
  2. Novo Nordisk (NYSE: NVO)
    3. /

Novo Nordisk (NYSE: NVO) Share Price and News

$49.57 $0.64 (1.3%) 14 February 2026 at 8:00:00 am AEDT

Novo Nordisk Chart and Price Data

About Novo Nordisk

Last updated 14-02-2026, 08:00:00am AEDT
Current Price $49.57
Change $0.64 (1.3%)
Close Price $49.57
Open Price $49.30
Bid $49.31
Ask $49.57
Day Range $49.20 - $49.84
Year Range $43.08 - $93.80
Volume 10,156,106
Average Volume 21,513,278
Market Cap $167,007,774,100.00
Earnings Per Share $3.47

    • Novo Nordisk (NYSE: NVO)
    Latest News

    Group of young people stacking hands together in an outdoor setting. A community of multiracial international people supporting each other.
    ETFs

    3 ASX ETFs that could be perfect for beginner investors

    | James Mickleboro

    If you're new to the world of investing then it could be worth checking out these funds.

    Read more »

    A doctor appears shocked as he looks through binoculars on a blue background.
    Healthcare Shares

    Ozempic maker Novo Nordisk plunges 22%. What could this mean for Resmed shares?

    | Kevin Gandiya

    Novo Nordisk just lost $100 billion in market value.

    Read more »

    A person eats a meat pie on the beach... what's more Australian than that?
    Consumer Staples & Discretionary Shares

    Which ASX shares could be next on the menu for Ozempic?

    | Mitchell Lawler

    This broker believes the market for weight-loss drugs could grow tenfold. What could it consume on its way up?

    Read more »

    Shot of two young scientists using a laptop in a laboratory.
    Healthcare Shares

    How can ASX investors buy the US stock the WHOLE world is talking about?

    | Sebastian Bowen

    Want to know how to buy the international stock du jour from the comfort of the ASX? Read on!

    Read more »

    medical asx share price represented by doctor giving thumbs up
    ETFs

    'Beyond our expectations': How to invest in obesity drugs like Ozempic with ASX ETFs

    | James Mickleboro

    This could be your way to invest in obesity drugs.

    Read more »

    Profile

    since

    Note